Areas of Interest
LIVFRESH Dental Gel toothpaste
is already approved in EU
for Prevention & Treatment of Periodontitis, Gingivitis, & Caries
FEATURED IN
PLAQUE CONTROL
We have the first breakthrough in the dental industry since the introduction of fluoride in 1914.
LIVFRESH Dental Gel toothpaste is clinically proven to remove plaque 250% BETTER than a market leader.
All ingredients are edible and contain ZERO abrasives, antimicrobials, parabens, gluten, sugar, triclosan, & SLS.
LIVFRESH is commercially available in USA.
Dental get Tubes sold
# of Customers
5-Star Reviews
REFERENCE: PMID 26052472
PERIODONTITIS
Periodontitis is a serious gum disease whose progression can be delayed by in office procedures like scaling and root planing (SRP), 3 monthly professional cleaning, etc. In contrast, gingivitis is characterized by gum inflammation/bleeding and is generally considered reversible. Periodontitis leads to significant discomfort/pain, loss of teeth, and a substantial decrease in the quality of life. Periodontitis has also been linked to dementia, Alzheimer’s, cardiac disease, and other systemic diseases.
Prevalance
64M
PATIENTS IN THE US
Increasing prevalence due to the aging population and the lack of availability of effective home care. According to the CDC, at least 47% of all US adults above 30 years, suffer from periodontitis.
Current standard of care are in-office treatments to slow down progression of periodontitis which can be painful, time-intensive, and expensive. Baseline treatments include scaling and root planing, and professional cleanings every 3 months. Surgery is suggested for advanced cases.
LIVFRESH Dental Gel toothpaste
Possible first affordable at-home treatment
Double-Blind Study Shows Reduction of Pocket Depths
Pocket Depth > 4 mm are a marker for periodontitis. In the double-blind study, the LIVFRESH group showed significant reductions in diseased pocket depths, gum inflammation, gum bleeding and dental plaque.
Ready to launch FDA Phase 2 study
Approval would make LIVFRESH the first affordable, at-home treatment for severe gum disease in USA
LIVFRESH is planning to launch an anti-gingivitis toothpaste in 2025
Clinical Parameters Associated with Gingivitis
Superior Efficacy versus Leading Brand Anti-Gingivitis Toothpastes
3-Month Randomized Controlled Trial (RCT) in 150 Patients with Gingivitis – 30 Patients per Study Arm
REFERENCE: PMID 37016272